These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35508440)

  • 61. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
    Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
    Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
    Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Takotsubo cardiomyopathy and Parkinson's disease: An exceptionally uncommon clinical duet.
    Lazaros G; Dimitriadis K; Xanthopoulou M; Latsios G; Antoniou C; Lazarou E; Tousoulis D
    Hellenic J Cardiol; 2019; 60(5):334-335. PubMed ID: 30572116
    [No Abstract]   [Full Text] [Related]  

  • 64. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
    Sieweke JT; Pfeffer TJ; Berliner D; König T; Hallbaum M; Napp LC; Tongers J; Kühn C; Schmitto JD; Hilfiker-Kleiner D; Schäfer A; Bauersachs J
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):173-182. PubMed ID: 29792513
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Left ventricular unloading in cardiogenic shock].
    Schäfer A; Bauersachs J
    Herz; 2017 Feb; 42(1):18-26. PubMed ID: 27928595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiogenic shock induced by Takotsubo cardiomyopathy in early postoperative adrenalectomy period.
    Pérez Benítez SE; Pastor Ramírez O; Salazar Bonilla CJ; Solera Marín J
    Rev Esp Anestesiol Reanim (Engl Ed); 2019 May; 66(5):288-291. PubMed ID: 30665798
    [TBL] [Abstract][Full Text] [Related]  

  • 68. First experience with implantation of a percutaneous right ventricular Impella right side percutaneous support device as a bridge to recovery in acute right ventricular infarction complicated by cardiogenic shock in the United States.
    Margey R; Chamakura S; Siddiqi S; Senapathi M; Schilling J; Fram D; Hirst J; Saddiq I; Silverman D; Kiernan F
    Circ Cardiovasc Interv; 2013 Jun; 6(3):e37-8. PubMed ID: 23780299
    [No Abstract]   [Full Text] [Related]  

  • 69. A single healthcare experience with Impella RP.
    Shekiladze N; Condado JF; Sandesara PB; Kim JH; Devireddy C; McDaniel M; Babaliaros V; Samady H; Kumar G; Jaber WA
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E161-E167. PubMed ID: 32569445
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Percutaneous Mechanical Circulatory Support Using Impella Devices for Decompensated Cardiogenic Shock: A Pediatric Heart Center Experience.
    Parekh D; Jeewa A; Tume SC; Dreyer WJ; Pignatelli R; Horne D; Justino H; Qureshi AM
    ASAIO J; 2018; 64(1):98-104. PubMed ID: 28394814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A femoral Impella
    Vandenbriele C; Nijs S; Rega F; Balthazar T
    Acta Cardiol; 2023 Apr; 78(2):267-268. PubMed ID: 36729027
    [No Abstract]   [Full Text] [Related]  

  • 72. Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery.
    La Torre MW; Centofanti P; Attisani M; Patanè F; Rinaldi M
    Tex Heart Inst J; 2011; 38(1):42-9. PubMed ID: 21423467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
    Laliberte B; Reed BN
    Am J Health Syst Pharm; 2017 May; 74(9):e163-e169. PubMed ID: 28438820
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trends and Impact of the Use of Mechanical Circulatory Support for Cardiogenic Shock Secondary to Takotsubo Cardiomyopathy.
    Napierkowski S; Banerjee U; Anderson HV; Charitakis K; Madjid M; Smalling RW; Dhoble A
    Am J Cardiol; 2021 Jan; 139():28-33. PubMed ID: 33035466
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
    Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Takotsubo Syndrome in Intensive Cardiac Care Unit: Challenges in Diagnosis and Management.
    Montone RA; La Vecchia G; Del Buono MG; Abbate A; Sanna T; Pedicino D; Niccoli G; Antonelli M; Crea F
    Curr Probl Cardiol; 2022 Nov; 47(11):101084. PubMed ID: 34942270
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Tarantini G; Masiero G; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Mojoli M; Casu G; Giustino G; Lorenzoni G; Montorfano M; Ancona MB; Pappalardo F; Chieffo A;
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E222-E234. PubMed ID: 33793051
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiogenic Shock in Takotsubo Cardiomyopathy Versus Acute Myocardial Infarction: An 8-Year National Perspective on Clinical Characteristics, Management, and Outcomes.
    Vallabhajosyula S; Dunlay SM; Murphree DH; Barsness GW; Sandhu GS; Lerman A; Prasad A
    JACC Heart Fail; 2019 Jun; 7(6):469-476. PubMed ID: 31078481
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insertion of Impella CP following postcardiotomy cardiogenic shock concomitant with veno-arterial extracorporeal membrane oxygenation.
    Iida Y; Tamai K; Oka H; Inaba Y; Miki T; Takahashi H; Hachiya T; Shimizu H
    Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1144-1146. PubMed ID: 33788168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.